Skip to content

Opko Health OPK Common Stock

Common Stock at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$2M0.0%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$8K+14.3%
HRO
HarrowHROW
50M0.0%
Precigen logo
PrecigenPGEN
$0
Immunome logo
ImmunomeIMNM
$11K+22.2%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0-100%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's common stock?
Opko Health (OPK) reported common stock of $7.85M in Q1 2026.
How has Opko Health's common stock changed year-over-year?
Opko Health's common stock increased by 11.9% year-over-year, from $7.02M to $7.85M.
What is the long-term trend for Opko Health's common stock?
Over 5 years (2020 to 2025), Opko Health's common stock has grown at a 3.3% compound annual growth rate (CAGR), from $6.71M to $7.9M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).